The global pharmaceutical plastic bottles market is estimated to be valued at USD 11.06 Bn in 2025 and is expected to reach USD 15.57 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.0% from 2025 to 2032.

To learn more about this report, Download Free Sample
Increasing healthcare spending across countries and rising demand for lightweight, safe, and tamper proof packaging from pharmaceutical companies has been driving the demand for pharmaceutical plastic bottles. Moreover, plastic as a material for pharmaceutical packaging offers benefits over other traditional materials like glass as plastic bottles are much lighter in weight and provide better protection to drugs from breakage. Plastic also acts as barrier to moisture, gas, and light, thereby increasing the shelf life of drugs. Rapid growth of pharmaceutical industry coupled with consumer preference for advanced packaging will continue supporting the market expansion for pharmaceutical plastic bottles.
|
Current Events |
Description and its impact |
|
Global Regulatory Shifts on Single-Use Plastics |
|
|
Supply Chain Disruptions Due to Geopolitical Tensions |
|
|
Economic Trends Affecting Raw Material Pricing |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Polyethylene Terephthalate (PET) segment is expected to contribute 46.1% share of the market in 2025. PET provides excellent protection against permeation of oxygen, carbon dioxide, and moisture vapor, thus ensuring long shelf-life for packaged pharmaceutical products. Its high tensile strength and shatter resistance allows it to withstand fall impacts and bumps during transportation and storage. PET material is also lightweight yet sturdy, making it cost-effective for producers to transport larger volumes. For instance, in January 2025, Loop Industries, Inc., a clean technology company focused on advancing a circular plastics economy through the production of 100% recycled polyethylene terephthalate (PET) plastic and polyester fiber, partnered with Bormioli Pharma, a global leader in pharmaceutical packaging and medical devices, to unveil an innovative pharmaceutical packaging bottle. This new bottle, made entirely from virgin-quality Loop™ PET resin, will be showcased at the Bormioli booth, highlighting the companies’ commitment to sustainability and innovation in medical packaging. This is further propelling the pharmaceutical plastic bottles market share.
Rigid Bottles segment is expected to contribute 47.3% share of the market in 2025, owing to their multi-purpose utility and tamper-evidence. Rigid bottles keep pharmaceutical products safer and more potent than flexible pouches through effective barrier protection. Their sturdiness enables vertical storage without stacking concerns. The rigidity allows for precision dosing via integrated measuring cups or dropper caps. Additionally, rigid bottles provide better grips than flexible pouches for users of all ages and abilities. For instance, in April 2025, Coveris, a leading packaging manufacturer, launched SleeveFlexR Stretch, a new circular stretch sleeve solution containing up to 75% recycled content. In alignment with PPWR regulations, the company is increasing the use of post-consumer recycled (PCR) material in rigid plastic bottles, which may alter their appearance while enhancing sustainability. This is further adding to the pharmaceutical plastic bottles market revenue.
Oral Medications segment is expected to contribute 49% share of the market in 2025. For oral medications, plastic bottles facilitate reliable twice-daily or thrice-daily self-administration through straightforward dispensing regimes. Consumers appreciate bottles over blister packs for their intuitive dosing via dedicated cavities. The bottles' portability and direct observability of remaining quantity encourage treatment compliance.

To learn more about this report, Download Free Sample
The North America pharmaceutical plastic bottles market is growing rapidly as manufacturers respond to the increasing demand for safe and sustainable packaging solutions. The rise in chronic diseases and an aging population drives the need for oral medication packaging. Companies are innovating with child-resistant and tamper-evident designs to improve patient safety. Additionally, regulatory requirements and environmental concerns encourage manufacturers to use recyclable materials like PET and HDPE. This shift toward lightweight, durable, and convenient packaging is actively shaping the market across the region. For instance, in May 2025, SC Johnson launched its first refill machine in North America at London Drugs, a Canadian retailer and drugstore. This initiative enables consumers to refill reusable bottles with hand or dish soap from popular brands like Method and Mrs. Meyer's Clean Day, promoting sustainability and reducing single-use plastic waste.
Asian manufacturers are increasingly choosing PET plastic bottles because of their lightweight nature, low cost, and versatile designs. PET bottles comply with strict safety and quality standards, making them ideal for pharmaceutical packaging. The rise in chronic diseases and aging population in the Asia-Pacific region drives the demand for pharmaceuticals. This demographic change requires the use of efficient packaging solutions to ensure medicine stability, ease of use, and accurate dosing. For instance, in June 2025, PT Asia Pramulia, a plastic packaging manufacturer, has announced its plans to go public through an initial public offering (IPO) on the Indonesia Stock Exchange. The company will allocate 50% of the IPO proceeds to purchase new production machinery, which will enhance its packaging operations across various sectors, including beverages, food, paint, cosmetics, chemicals, pharmaceuticals, and utility support products.
Pharmaceutical makers in the United States are quickly integrating smart technologies such as QR codes, NFC chips, and temperature sensors into plastic bottles. These technologies enhance product traceability, prevent counterfeiting, and engage consumers by providing real-time information and personalized content. Rising safety concerns drive manufacturers to develop advanced child-resistant and tamper-evident packaging, improving closures and designs to prevent accidental ingestion while complying with regulations and building consumer trust. For instance, in June 2023, New York-based sustainable health care company Cabinet Health, known for developing a refillable and compostable medicine system, introduced its first nationwide pill bottle recycling program to tackle the issue of pharmaceutical plastic waste.
China’s aging population is causing a rise in chronic diseases, which drives higher demand for pharmaceuticals. This demographic change requires manufacturers to use effective packaging techniques that ensure drug stability, ease of use, and accurate dosing. Pharmaceutical plastic bottles play a key role in meeting these standards. Chinese manufacturers increasingly prefer PET plastic bottles because they are lightweight, cost-effective, and versatile in design. PET bottles also meet strict safety and quality standards, making them ideal for pharmaceutical packaging. For instance, in July 2022, The Coca-Cola Company, after recently streamlining its brand portfolio by cutting over 200 products, introduced Self-Heal Spike, its first bottled Chinese herbal tea, as part of its effort to expand its healthy beverage offerings. This is further accelerating the pharmaceutical plastic bottles market growth.

To learn more about this report, Download Free Sample
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 11.06 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 5.0% | 2032 Value Projection: | USD 15.57 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Amcor Plc, Gerresheimer AG, AptarGroup, Inc., Berry Global, Inc., West Pharmaceutical Services, Inc., RPC Group Plc, Sanner GmbH, Comar LLC, Alpack Plastics, Inc., Indevco Group, Shandong Minde Plastic Co., Ltd., HCP Packaging, Shenzhen Dazheng Printing Co., Ltd., Sidel Group, and Plastipak Holdings, Inc. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Pharmaceutical companies are increasingly incorporating smart packaging features such as QR codes, NFC chips, and temperature sensors into plastic bottles. These technologies enhance product traceability by allowing real-time tracking throughout the supply chain and help combat counterfeiting by verifying authenticity. Additionally, smart packaging improves consumer engagement by providing personalized information and dosage reminders, ultimately promoting better medication adherence and safety. This trend reflects the industry's focus on innovation and leveraging digital tools to enhance packaging functionality.
Safety concerns are driving the pharmaceutical industry to prioritize child-resistant and tamper-evident packaging designs. Manufacturers are developing advanced closure systems that prevent accidental ingestion by children while remaining user-friendly for adults, especially seniors. Tamper-evident features provide visible signs if a package has been opened or altered, increasing consumer confidence and meeting stringent regulatory standards.
Emerging economies in Asia-Pacific, Latin America, and Africa present significant growth opportunities for pharmaceutical plastic bottle manufacturers. Rising healthcare awareness, expanding medical infrastructure, and increasing government support for healthcare access are driving pharmaceutical demand in these regions. Companies can capitalize on this by offering cost-effective, locally tailored packaging solutions. Understanding regional regulatory requirements and consumer preferences will help businesses establish a strong foothold and cater to growing pharmaceutical production and distribution networks.
Share
Share
About Author
Vidyesh Swar is a seasoned Consultant with a diverse background in market research and business consulting. With over 6 years of experience, Vidyesh has established a strong reputation for his proficiency in market estimations, supplier landscape analysis, and market share assessments for tailored research solution. Using his deep industry knowledge and analytical skills, he provides valuable insights and strategic recommendations, enabling clients to make informed decisions and navigate complex business landscapes.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients